Filing Details

Accession Number:
0001209191-20-056390
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-02 14:00:55
Reporting Period:
2020-10-29
Accepted Time:
2020-11-02 14:00:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750019 Tcr2 Therapeutics Inc. TCRR Biological Products, (No Disgnostic Substances) (2836) 474152751
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760102 Robert Hofmeister C/O Tcr2 Therapeutics
100 Binney Street
Cambridge MA 02142
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-29 20,000 $0.74 58,850 No 4 M Direct
Common Stock Disposition 2020-10-29 20,000 $19.10 38,850 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-10-29 20,000 $0.00 20,000 $0.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,346 2018-12-07 2027-12-07 No 4 M Direct
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on by the reporting person.
  2. 25% of this option vested and become exercisable on December 7, 2018, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.